HOOKIPA Pharma Inc (HOOK)
Cours de l'action
Loading...
•
Achat
•
Vente
•
Achat planifié
•
Vente planifiée
Achat net
Vente nette
Résultats financiers
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2023-08-22 | 2023-08-21 | A Achat |
Chief Financial Officer Administrateur exécutif |
7 000
+19.4%
0,735 075 USD |
7 000 +19.4% | 0,73 | 5 075 USD | |
| 2023-08-17 | 2023-08-16 | A Achat |
Chief Financial Officer Administrateur exécutif |
8 000
+28.5%
0,715 712 USD |
8 000 +28.5% | 0,71 | 5 712 USD | |
| 2023-07-11 | 2023-07-11 | A Achat |
Chief Executive Officer Administrateur exécutif |
5 000
+7.5%
0,834 142 USD |
5 000 +7.5% | 0,83 | 4 142 USD | |
| 2023-07-11 | 2023-07-07 | A Achat |
Chief Executive Officer Administrateur exécutif |
5 000
+8.1%
0,814 050 USD |
5 000 +8.1% | 0,81 | 4 050 USD | |
| 2023-07-07 | 2023-07-05 | A Achat |
Chief Executive Officer Administrateur exécutif |
5 000
+8.8%
0,894 450 USD |
5 000 +8.8% | 0,89 | 4 450 USD | |
| 2023-07-05 | 2023-07-03 | A Achat |
Chief Executive Officer Administrateur exécutif |
5 000
+9.6%
0,894 456 USD |
5 000 +9.6% | 0,89 | 4 456 USD | |
| 2023-07-03 | 2023-06-30 | A Achat |
Chief Financial Officer Administrateur exécutif |
12 000
+74.6%
0,8810 560 USD |
12 000 +74.6% | 0,88 | 10 560 USD | |
| 2022-01-12 | 2021-12-21 | V Vente |
Chief Medical Officer Dirigeant |
2 205
-2.5%
2,495 490 USD |
2 205 -2.5% | 2,49 | 5 490 USD | |
| 2022-01-12 | 2021-12-21 | V Vente |
Chief Medical Officer Dirigeant |
7 440
-8.1%
2,4918 526 USD |
7 440 -8.1% | 2,49 | 18 526 USD | |
| 2022-01-12 | 2021-12-21 | V Vente |
Chief Medical Officer Dirigeant |
5 304
-6.2%
2,4913 207 USD |
5 304 -6.2% | 2,49 | 13 207 USD | |
| 2021-04-23 | 2021-04-21 | V Vente | Actionnaire important |
328 620
-9.4%
11,603 812 386 USD |
328 620 -9.4% | 11,60 | 3 812 386 USD | |
| 2021-03-29 | 2021-03-25 | VP Vente planifiée | Actionnaire important |
28 546
-0.8%
13,12374 569 USD |
28 546 -0.8% | 13,12 | 374 569 USD | |
| 2021-03-26 | 2021-03-24 | VP Vente planifiée | Actionnaire important |
52 690
-1.4%
13,70721 616 USD |
52 690 -1.4% | 13,70 | 721 616 USD | |
| 2021-03-25 | 2021-03-23 | VP Vente planifiée | Actionnaire important |
40 000
-1.1%
13,91556 476 USD |
40 000 -1.1% | 13,91 | 556 476 USD | |
| 2021-03-24 | 2021-03-22 | VP Vente planifiée | Actionnaire important |
40 534
-1.1%
14,54589 263 USD |
40 534 -1.1% | 14,54 | 589 263 USD | |
| 2021-03-23 | 2021-03-19 | VP Vente planifiée | Actionnaire important |
166 230
-4.3%
14,602 427 739 USD |
166 230 -4.3% | 14,60 | 2 427 739 USD | |
| 2020-12-18 | 2020-12-17 | V Vente |
Chief Medical Officer Dirigeant |
16 478
-17.6%
11,76193 781 USD |
16 478 -17.6% | 11,76 | 193 781 USD | |
| 2020-12-18 | 2020-12-17 | V Vente |
Chief Medical Officer Dirigeant |
11 501
-15.2%
11,70134 562 USD |
11 501 -15.2% | 11,70 | 134 562 USD | |
| 2020-12-18 | 2020-12-16 | V Vente |
Chief Medical Officer Dirigeant |
380
-0.7%
11,704 446 USD |
380 -0.7% | 11,70 | 4 446 USD | |
| 2020-10-06 | 2020-10-02 | VP Vente planifiée | Actionnaire important |
300
-0.0%
10,003 000 USD |
300 -0.0% | 10,00 | 3 000 USD | |
| 2020-09-17 | 2020-09-15 | VP Vente planifiée | Actionnaire important |
9 261
-0.2%
13,16121 913 USD |
9 261 -0.2% | 13,16 | 121 913 USD | |
| 2020-09-17 | 2020-09-15 | VP Vente planifiée | Actionnaire important |
32 336
-0.8%
12,45402 564 USD |
32 336 -0.8% | 12,45 | 402 564 USD | |
| 2020-07-22 | 2020-07-20 | VP Vente planifiée | Actionnaire important |
12 483
-0.3%
11,94149 102 USD |
12 483 -0.3% | 11,94 | 149 102 USD | |
| 2020-07-22 | 2020-06-29 | VP Vente planifiée | Actionnaire important |
3 280
-0.1%
11,7838 628 USD |
3 280 -0.1% | 11,78 | 38 628 USD | |
| 2020-07-01 | 2020-06-29 | VP Vente planifiée | Actionnaire important |
3 280
-0.1%
11,7838 628 USD |
3 280 -0.1% | 11,78 | 38 628 USD | |
| 2020-01-31 | 2020-01-29 | V Vente |
Chief Medical Officer |
5 500
-9.3%
12,7369 992 USD |
5 500 -9.3% | 12,73 | 69 992 USD | |
| 2020-01-27 | 2020-01-23 | V Vente |
Sr. VP, Technical Development |
7 568
-100.0%
12,8196 932 USD |
7 568 -100.0% | 12,81 | 96 932 USD | |
| 2020-01-27 | 2020-01-23 | V Vente |
Sr. VP, Technical Development |
4 075
-100.0%
12,1749 601 USD |
4 075 -100.0% | 12,17 | 49 601 USD | |
| 2020-01-21 | 2020-01-21 | V Vente |
Sr. VP, Research |
6 789
-100.0%
12,0281 592 USD |
6 789 -100.0% | 12,02 | 81 592 USD | |
| 2020-01-21 | 2020-01-16 | V Vente |
Sr. VP, Research |
1 711
-100.0%
11,5619 781 USD |
1 711 -100.0% | 11,56 | 19 781 USD | |
| 2020-01-16 | 2020-01-14 | V Vente |
Sr. VP, Research |
8 500
-100.0%
11,3096 053 USD |
8 500 -100.0% | 11,30 | 96 053 USD | |
| 2019-12-23 | 2019-12-19 | V Vente |
Matushansky Igor Chief Medical Officer Dirigeant |
10 404
-15.0%
9,93103 312 USD |
10 404 -15.0% | 9,93 | 103 312 USD | |
| 2019-12-19 | 2019-12-17 | V Vente |
Matushansky Igor Chief Medical Officer Dirigeant |
11 484
-20.9%
7,8790 379 USD |
11 484 -20.9% | 7,87 | 90 379 USD | |
| 2019-04-25 | 2019-04-23 | A Achat |
Forbion Capital Fund II Cooperatief U.A. Actionnaire important |
53 571
+2.2%
14,00749 994 USD |
53 571 +2.2% | 14,00 | 749 994 USD | |
| 2019-04-25 | 2019-04-23 | A Achat | Actionnaire important |
357 142
+9.9%
14,004 999 988 USD |
357 142 +9.9% | 14,00 | 4 999 988 USD | |
| 2019-04-23 | 2019-04-23 | A Achat |
Former 10% owner |
820 729
+inf%
14,0011 490 206 USD |
820 729 +inf% | 14,00 | 11 490 206 USD | |
| 2019-04-23 | 2019-04-23 | A Achat |
Former 10% owner |
72 128
+inf%
14,001 009 792 USD |
72 128 +inf% | 14,00 | 1 009 792 USD |